Provided by Tiger Trade Technology Pte. Ltd.

Abbott Laboratories

96.69
-2.1400-2.17%
Post-market: 96.850.1600+0.17%19:56 EDT
Volume:8.86M
Turnover:862.35M
Market Cap:168.13B
PE:31.29
High:99.45
Open:99.10
Low:96.54
Close:98.83
52wk High:135.45
52wk Low:81.97
Shares:1.74B
Float Shares:1.70B
Volume Ratio:1.22
T/O Rate:0.52%
Dividend:2.48
Dividend Rate:2.56%
EPS(TTM):3.09
EPS(LYR):3.73
ROE:10.58%
ROA:5.33%
PB:3.29
PE(LYR):25.92

Loading ...

Abbott Agrees to Pay $385 Million to Settle DOJ Claims over 2022 Infant Formula Recall

Reuters
·
Sep 14

Abbott: no Unopened, Distributed Abbott Infant Formulas Have Ever Tested Positive for Cronobacter Sakazakii

THOMSON REUTERS
·
Sep 14

Abbott Reaches Agreement with Department of Justice to Resolve Claims Relating to 2022 Infant Formula Recall

THOMSON REUTERS
·
Sep 14

Abbott - to Pay $385 Mln to Resolve Claims; no Finding of Fault or Liability

THOMSON REUTERS
·
Sep 14

U.S. Justice Department Says Abbott Agrees to Pay over $384M to Settle Allegations Related to Contaminated Infant Formula

THOMSON REUTERS
·
Sep 14

Abbott to pay over $384M to settle infant formula allegations

TIPRANKS
·
Sep 14

Agilent Technologies Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 12

Edwards Lifesciences Corp. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Sep 12

Texas Gov. Abbott, Seeking Re-Election, Touts Border Security, Voter ID Law

Dow Jones
·
Sep 11

Perrigo Co. PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Abbott Laboratories Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Sep 11

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Pharvaris (PHVS) and Zimmer Biomet Holdings (ZBH)

TIPRANKS
·
Sep 09

Edwards Lifesciences Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Medtronic PLC Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Sep 09

Abbott Laboratories Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09

Abbott Labs Price Target Maintained with a $135.00/Share by TD Cowen

Dow Jones
·
Sep 08

Abbott Wins FDA Approval for TactiFlex Duo Dual-Energy AFib Ablation Catheter

Reuters
·
Sep 08

Abbott Receives FDA Approval for Its Tactiflex™ Duo Ablation Catheter to Treat People with Abnormal Heart Rhythms

THOMSON REUTERS
·
Sep 08

Abbott - to Begin Broader Commercial Adoption of Tactiflex Duo in U.S. in Coming Weeks

THOMSON REUTERS
·
Sep 08

Asep Medical Restructures Stakes in ABT and Sepset While Preserving Economic Upside

TIPRANKS
·
Sep 06